Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters.

Pellegrin, Isabelle

Can highly active antiretroviral therapy be interrupted in patients with sustained moderate HIV RNA and > 400 CD4+ cells/microl? Impact on immunovirological parameters. [electronic resource] - Journal of medical virology Oct 2005 - 164-72 p. digital

Publication Type: Journal Article

0146-6615

10.1002/jmv.20452 doi


Anti-HIV Agents--administration & dosage
Antiretroviral Therapy, Highly Active
CD4 Lymphocyte Count
DNA, Viral--blood
Drug Administration Schedule
Drug Resistance, Multiple, Viral
Female
Genotype
HIV Infections--blood
HIV-1--drug effects
Humans
Leukocytes, Mononuclear--drug effects
Male
Middle Aged
Mutation
RNA, Viral--blood
Viral Load